Breast cancer growth is inhibited by vasoactive intestinal peptide (VIP) hybrid, a synthetic VIP receptor antagonist (Q71400924)
Jump to navigation
Jump to search
scientific article published on 01 August 1996
Language | Label | Description | Also known as |
---|---|---|---|
English | Breast cancer growth is inhibited by vasoactive intestinal peptide (VIP) hybrid, a synthetic VIP receptor antagonist |
scientific article published on 01 August 1996 |
Statements
Breast cancer growth is inhibited by vasoactive intestinal peptide (VIP) hybrid, a synthetic VIP receptor antagonist (English)
Zia H
Hida T
Jakowlew S
Birrer M
Gozes Y
Reubi JC
Fridkin M
Gozes I